{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:31:15Z","timestamp":1780709475213,"version":"3.54.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":3504,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Veterinary Diagnostics Institute, Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Serum thymidine kinase type 1 (TK1) and canine C-Reactive Protein (cCRP) might be useful in detecting dogs with cancer. Algorithms combining biomarkers are sometimes more accurate than results of individual tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aim of this study was to compare serum TK1 and cCRP and Neoplasia Index (NI) in healthy and tumor-bearing dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Client-owned dogs with (n\u00a0=\u00a0253) and without (n\u00a0=\u00a0156) cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective case\u2013control study. Dogs with cancer were identified after submission of samples for commercial assay and case details were retrospectively collected. Healthy dogs (control) were identified through breed groups and health status was confirmed by health questionnaire for a minimum of 6\u00a0months. Serum TK1 activity was measured using a quantitative chemiluminescent assay and serum cCRP was measured using a quantitative ELISA assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TK1 activity in the cancer (n\u00a0=\u00a0253) and control group (n\u00a0=\u00a0156) were 7.0 \u03bc\/L (median, range &amp;lt;0.5 to &amp;gt;100) and 1.8 \u03bc\/L (median, range 0.4 to 55.3), respectively (P\u00a0&amp;lt;\u00a0.001). cCRP concentrations in the cancer and control group were 6.0\u00a0mg\/L (median, range &amp;lt;0.5 to &amp;gt;50) and 1.6\u00a0mg\/L (median, range 0.09 to &amp;gt;50), respectively (P\u00a0&amp;lt;\u00a0.001). The NI in the cancer and control group were 6.4 (median, range 0\u20139.9) and 0.9 (median, range 0\u20137.6), respectively (P\u00a0&amp;lt;\u00a0.001). ROC AUCs of the NI and TK1 for all cancers were greater than 0.8, highest for lymphoma and histiocytic sarcoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Increased concentrations of TK1 and cCRP, when present in dogs with cancer, might be useful in confirming a diagnosis and monitoring response to treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.13954","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T10:42:26Z","timestamp":1464086546000},"page":"1159-1166","source":"Crossref","is-referenced-by-count":28,"title":["Thymidine Kinase Type 1 and C-Reactive Protein Concentrations in Dogs with Spontaneously Occurring Cancer"],"prefix":"10.1093","volume":"30","author":[{"given":"K.A.","family":"Selting","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, University of Missouri Department of Veterinary Medicine and Surgery, , Columbia, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ringold","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Institute, Inc. , Simi Valley, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Husbands","sequence":"additional","affiliation":[{"name":"BluePearl Veterinary Partners , Eden Prarie, MN"},{"name":"College of Veterinary Medicine, University of Minnesota , St. Paul, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.O.","family":"Pithua","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, University of Missouri Department of Veterinary Medicine and Surgery, , Columbia, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,7,1]]},"reference":[{"key":"2026020304522169300_jvim13954-bib-0001","first-page":"2070","article-title":"Tumor-associated thymidine kinase in the sera of rats with transplanted hepatomas","volume":"36","author":"Taylor","year":"1976","journal-title":"Cancer Res"},{"key":"2026020304522169300_jvim13954-bib-0002","first-page":"691","article-title":"Thymidine kinase isoenzymes in human malignant lymphoma","volume":"41","author":"Ellims","year":"1981","journal-title":"Cancer Res"},{"key":"2026020304522169300_jvim13954-bib-0003","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/bjc.1983.78","article-title":"The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma","volume":"47","author":"Gronowitz","year":"1983","journal-title":"Br J Cancer"},{"key":"2026020304522169300_jvim13954-bib-0004","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/bjc.1995.213","article-title":"Deoxythymidine kinase in the tumour cells and serum of patients with non-Hodgkin lymphomas","volume":"71","author":"Rehn","year":"1995","journal-title":"Br J Cancer"},{"key":"2026020304522169300_jvim13954-bib-0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2141.1995.tb03386.x","article-title":"Clinical significance of serum thymidine kinase in adult T-cell leukaemia and acute myeloid leukaemia","volume":"90","author":"Sadamori","year":"1995","journal-title":"Br J Haematol"},{"key":"2026020304522169300_jvim13954-bib-0006","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/bjc.1988.141","article-title":"Thymidine kinase activities in mononuclear leukocytes and serum from breast cancer patients","volume":"57","author":"McKenna","year":"1988","journal-title":"Br J Cancer"},{"key":"2026020304522169300_jvim13954-bib-0007","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/bjc.1991.309","article-title":"Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancer","volume":"64","author":"van der Gaast","year":"1991","journal-title":"Br J Cancer"},{"key":"2026020304522169300_jvim13954-bib-0008","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/bjc.1990.352","article-title":"Thymidine kinase in breast cancer","volume":"62","author":"Robertson","year":"1990","journal-title":"Br J Cancer"},{"key":"2026020304522169300_jvim13954-bib-0009","first-page":"3025","article-title":"Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma","volume":"17","author":"Poley","year":"1997","journal-title":"Anticancer Res"},{"key":"2026020304522169300_jvim13954-bib-0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3892\/mco.2012.19","article-title":"The proliferation marker thymidine kinase 1 in clinical use","volume":"1","author":"Zhou","year":"2013","journal-title":"Mol Clin Oncol"},{"key":"2026020304522169300_jvim13954-bib-0011","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1292\/jvms.59.957","article-title":"Plasma thymidine kinase activity in dogs with lymphoma and leukemia","volume":"59","author":"Nakamura","year":"1997","journal-title":"J Vet Med Sci"},{"key":"2026020304522169300_jvim13954-bib-0012","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1939-1676.2004.tb02608.x","article-title":"Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease","volume":"18","author":"von Euler","year":"2004","journal-title":"J Vet Intern Med"},{"key":"2026020304522169300_jvim13954-bib-0013","first-page":"595","article-title":"Serum thymidine kinase activity: an alternative to histologic markers of cellular proliferation in canine lymphoma","volume":"18","author":"Madewell","year":"2004","journal-title":"J Vet Intern Med"},{"key":"2026020304522169300_jvim13954-bib-0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1476-5829.2010.00238.x","article-title":"Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases","volume":"9","author":"von Euler","year":"2011","journal-title":"Vet Comp Oncol"},{"key":"2026020304522169300_jvim13954-bib-0015","first-page":"505","article-title":"Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity\u2013evaluation of a new, fully automated non-radiometric assay","volume":"34","author":"Von Euler","year":"2009","journal-title":"Int J Oncol"},{"key":"2026020304522169300_jvim13954-bib-0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1476-5829.2011.00296.x","article-title":"Thymidine kinase assay in canine lymphoma","volume":"11","author":"Elliott","year":"2013","journal-title":"Vet Comp Oncol"},{"key":"2026020304522169300_jvim13954-bib-0017","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1476-5829.2011.00298.x","article-title":"Elevated serum thymidine kinase activity in canine splenic hemangiosarcoma","volume":"10","author":"Thamm","year":"2012","journal-title":"Vet Comp Oncol"},{"key":"2026020304522169300_jvim13954-bib-0018","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/vco.12052","article-title":"Serum thymidine kinase 1 and C-reactive protein as biomarkers for screening clinically healthy dogs for occult disease","volume":"13","author":"Selting","year":"2015","journal-title":"Vet Comp Oncol"},{"key":"2026020304522169300_jvim13954-bib-0019","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12917-014-0228-1","article-title":"Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker","volume":"10","author":"Jagarlamudi","year":"2014","journal-title":"BMC Vet Res"},{"key":"2026020304522169300_jvim13954-bib-0020","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.tvjl.2013.05.036","article-title":"High levels of inactive thymidine kinase 1 polypeptide detected in sera from dogs with solid tumours by immunoaffinity methods: implications for in\u00a0vitro diagnostics","volume":"197","author":"Kiran","year":"2013","journal-title":"Vet J"},{"key":"2026020304522169300_jvim13954-bib-0021","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tvjl.2010.04.009","article-title":"Acute phase proteins: biomarkers of infection and inflammation in veterinary medicine","volume":"185","author":"Eckersall","year":"2010","journal-title":"Vet J"},{"key":"2026020304522169300_jvim13954-bib-0022","doi-asserted-by":"crossref","first-page":"936","DOI":"10.2460\/javma.233.6.936","article-title":"Development of a clinical severity index for dogs with acute pancreatitis","volume":"233","author":"Mansfield","year":"2008","journal-title":"J Am Vet Med Assoc"},{"key":"2026020304522169300_jvim13954-bib-0023","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1292\/jvms.70.127","article-title":"C-reactive protein concentration in dogs with various diseases","volume":"70","author":"Nakamura","year":"2008","journal-title":"J Vet Med Sci"},{"key":"2026020304522169300_jvim13954-bib-0024","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1939-1676.2007.tb01943.x","article-title":"Serum C-reactive protein concentration as an indicator of remission status in dogs with multicentric lymphoma","volume":"21","author":"Nielsen","year":"2007","journal-title":"J Vet Intern Med"},{"key":"2026020304522169300_jvim13954-bib-0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1939-165X.2009.00146.x","article-title":"C-reactive protein concentration in dogs with primary immune-mediated hemolytic anemia","volume":"38","author":"Griebsch","year":"2009","journal-title":"Vet Clin Pathol"},{"key":"2026020304522169300_jvim13954-bib-0026","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/1040638711407896","article-title":"C-reactive protein concentrations in serum of dogs with naturally occurring renal disease","volume":"23","author":"Raila","year":"2011","journal-title":"J\u00a0Vet Diagn Invest"},{"key":"2026020304522169300_jvim13954-bib-0027","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1748-5827.2010.00965.x","article-title":"Prognostic value of serum acute-phase proteins in dogs with parvoviral enteritis","volume":"51","author":"Kocaturk","year":"2010","journal-title":"J\u00a0Small Anim Pract"},{"key":"2026020304522169300_jvim13954-bib-0028","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1476-4431.2009.00462.x","article-title":"Use of C-reactive protein to predict outcome in dogs with systemic inflammatory response syndrome or sepsis","volume":"19","author":"Gebhardt","year":"2009","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020304522169300_jvim13954-bib-0029","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/jvim.12351","article-title":"Serum biomarkers of clinical and cytologic response in dogs with idiopathic immune-mediated polyarthropathy","volume":"28","author":"Foster","year":"2014","journal-title":"J Vet Intern Med"},{"key":"2026020304522169300_jvim13954-bib-0030","first-page":"1029","article-title":"Application of serum thymidine kinase 1 of 26 055 cases in health screening for early detection of premalignant\/early malignant tumors","volume":"39","author":"Cao","year":"2014","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"2026020304522169300_jvim13954-bib-0031","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1373\/clinchem.2003.030379","article-title":"Sensitive nonradiometric method for determining thymidine kinase 1 activity","volume":"50","author":"Ohrvik","year":"2004","journal-title":"Clin Chem"},{"key":"2026020304522169300_jvim13954-bib-0032","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1309\/AJCPHMYT93HUIZKW","article-title":"High serum thymidine kinase 1 level predicts poorer survival in patients with chronic lymphocytic leukemia","volume":"134","author":"Konoplev","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"2026020304522169300_jvim13954-bib-0033","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.rvsc.2005.05.001","article-title":"A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs","volume":"80","author":"von Euler","year":"2006","journal-title":"Res Vet Sci"},{"key":"2026020304522169300_jvim13954-bib-0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1536867X0900900101","article-title":"Estimation and comparison of receiver operating characteristic curves","volume":"9","author":"Pepe","year":"2009","journal-title":"Stata J"},{"key":"2026020304522169300_jvim13954-bib-0035","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1939-1676.2001.tb02326.x","article-title":"Cellular proliferation in tumors: a review of methods, interpretation, and clinical applications","volume":"15","author":"Madewell","year":"2001","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.13954","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvim.13954","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvim.13954","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/30\/4\/1159\/66690245\/jvim13954.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/30\/4\/1159\/66690245\/jvim13954.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:52:38Z","timestamp":1770112358000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/30\/4\/1159\/8452863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,1]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.13954","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,7]]},"published":{"date-parts":[[2016,7,1]]}}}